(People Images/iStock via Getty Images Plus)

People on the Move: December 2021

By Jenni Spinner

This month’s announcements of awards, expansions, name changes, hires, and other news includes items from CPhI, Almac Group, ICON, and other organizations.

While the renewals are a topic of concern for investors, analysts believe both CROs will see a re-up. (Image: iStock/shironosov)

Will Pfizer renew with Icon, Parexel? Analyst says yes

By Melissa Fassbender

This month marks the renewal period for Pfizer’s contract research organizations’ Icon and Parexel, and while revenues have been declining, analysts believe the pharma giant will renew with both companies.

Icon eyeing China

Icon eyeing China

By Nick Taylor

Icon is looking to expand its bioanalytical capacity in Asia, notably in China, and bolster its genomics, proteomics and cell-based assay capabilities, according to a VP who discussed diversification of the business.

Icon boosts bioanalytical presence through Prevalere buy

Icon boosts bioanalytical presence through Prevalere buy

By Gareth Macdonald

Icon's recent $43.2m acquisition of New York-based Prevalere Life Sciences is the latest part of the firm's expansion in the US CRO market. Outsourcing-Pharma spoke with Icon's VP of bioanalytical development, Brian O'Dwyer, and Prevalere...


Follow us


View more


Featured Suppliers